Boron neutron capture therapy for high-grade glioma

Boron neutron capture therapy for high-grade glioma - BNCT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-C000000298

Enrollment

Registered

2006-04-01

Start date

2005-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high-grade glioma

Interventions

intraoperative BNCT external beam BNCT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: histologic proof of WHO grade III or IV astrocytoma KPS of 50 or more supratentorial unilateral lesion within 7cm from the brain surface signed informed consent

Exclusion criteria

Exclusion criteria: seeding abnormal data in clinical labolatory tests double cancer allergy for boron compounds others

Design outcomes

Primary

Measure	Time frame
adverse effect	—

Secondary

Measure	Time frame
progression-free survival	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026